EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SYSTEMIC INFLAMMATION AND NUTRITIONAL STATUS AS PROGNOSTIC FACTORS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB

Yolanda José Ricardo Soares Manuel, Ananda Giovana Cabral Silva, Renata Erbert Contriciani, Leo Victor Kim, Sandra Regina Branbilla, Ligia M. Antunes Correa, Maria Carolina Santos Mendes, José Barreto Campello Carvalheira

Hematology, Transfusion and Cell Therapy · 2026-03 · 48 · 106334

DOI: 10.1016/j.htct.2026.106334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-03. Verfasst von Yolanda José Ricardo Soares Manuel und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Manuel, Y. J. R. S., Silva, A. G. C., Contriciani, R. E., Kim, L. V., Branbilla, S. R., Correa, L. M. A., Mendes, M. C. S., & Carvalheira, J. B. C. (2026). SYSTEMIC INFLAMMATION AND NUTRITIONAL STATUS AS PROGNOSTIC FACTORS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB. Hematology, Transfusion and Cell Therapy, 48, 106334. https://doi.org/10.1016/j.htct.2026.106334

Vancouver

Manuel YJRS, Silva AGC, Contriciani RE, Kim LV, Branbilla SR, Correa LMA, et al. SYSTEMIC INFLAMMATION AND NUTRITIONAL STATUS AS PROGNOSTIC FACTORS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB. Hematology, Transfusion and Cell Therapy. 2026;48:106334. doi:10.1016/j.htct.2026.106334

BibTeX
@article{Manuel2026,
  author = {Manuel, Yolanda José Ricardo Soares and Silva, Ananda Giovana Cabral and Contriciani, Renata Erbert and Kim, Leo Victor and Branbilla, Sandra Regina and Correa, Ligia M. Antunes and Mendes, Maria Carolina Santos and Carvalheira, José Barreto Campello},
  title = {SYSTEMIC INFLAMMATION AND NUTRITIONAL STATUS AS PROGNOSTIC FACTORS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2026},
  volume = {48},
  pages = {106334},
  doi = {10.1016/j.htct.2026.106334}
}
Kostenlos starten →